Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Determination of eumelanin and pheomelanin in melanomas using solid-phase extraction and high performance liquid chromatography-diode array detection (HPLC-DAD) analysis.

Rioux B, Rouanet J, Akil H, Besse S, Debiton E, Bouchon B, Degoul F, Quintana M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Apr 15;1113:60-68. doi: 10.1016/j.jchromb.2019.03.010. Epub 2019 Mar 11.

PMID:
30897406
2.

Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models.

Rondon A, Ty N, Bequignat JB, Quintana M, Briat A, Witkowski T, Bouchon B, Boucheix C, Miot-Noirault E, Pouget JP, Chezal JM, Navarro-Teulon I, Moreau E, Degoul F.

Sci Rep. 2017 Nov 2;7(1):14918. doi: 10.1038/s41598-017-15051-y.

3.

Annexin A1 localization and its relevance to cancer.

Boudhraa Z, Bouchon B, Viallard C, D'Incan M, Degoul F.

Clin Sci (Lond). 2016 Feb;130(4):205-20. doi: 10.1042/CS20150415. Review.

PMID:
26769657
4.

Development and Preliminary Evaluation of TFIB, a New Bimodal Prosthetic Group for Bioactive Molecule Labeling.

Billaud EM, Vidal A, Vincenot A, Besse S, Bouchon B, Debiton E, Miot-Noirault E, Miladi I, Rbah-Vidal L, Auzeloux P, Chezal JM.

ACS Med Chem Lett. 2014 Nov 24;6(2):168-72. doi: 10.1021/ml500423v. eCollection 2015 Feb 12.

5.

Characterization of pro-invasive mechanisms and N-terminal cleavage of ANXA1 in melanoma.

Boudhraa Z, Merle C, Mazzocut D, Chezal JM, Chambon C, Miot-Noirault E, Theisen M, Bouchon B, Degoul F.

Arch Dermatol Res. 2014 Dec;306(10):903-14. doi: 10.1007/s00403-014-1517-z. Epub 2014 Nov 2.

PMID:
25362540
6.

Annexin A1 in primary tumors promotes melanoma dissemination.

Boudhraa Z, Rondepierre F, Ouchchane L, Kintossou R, Trzeciakiewicz A, Franck F, Kanitakis J, Labeille B, Joubert-Zakeyh J, Bouchon B, Perrot JL, Mansard S, Papon J, Dechelotte P, Chezal JM, Miot-Noirault E, Bonnet M, D'Incan M, Degoul F.

Clin Exp Metastasis. 2014 Oct;31(7):749-60. doi: 10.1007/s10585-014-9665-2. Epub 2014 Jul 6.

PMID:
24997993
7.

Complementary mass spectrometric approaches and scanning electron microscopy to study the structural stability of polyurethane tunneled dialysis catheters after exposure to ethanol solutions.

Msakni N, Galmier MJ, Couret MJ, Szczepaniak C, Bouchon B, Souweine B, Lartigue C.

Rapid Commun Mass Spectrom. 2013 Nov 15;27(21):2343-54. doi: 10.1002/rcm.6691.

PMID:
24097390
8.

ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides.

Dubois D, Baron O, Cougnoux A, Delmas J, Pradel N, Boury M, Bouchon B, Bringer MA, Nougayrède JP, Oswald E, Bonnet R.

J Biol Chem. 2011 Oct 14;286(41):35562-70. doi: 10.1074/jbc.M111.221960. Epub 2011 Jul 27.

9.

Intramolecular cyclization of N-phenyl N'(2-chloroethyl)ureas leads to active N-phenyl-4,5-dihydrooxazol-2-amines alkylating β-tubulin Glu198 and prohibitin Asp40.

Trzeciakiewicz A, Fortin S, Moreau E, C-Gaudreault R, Lacroix J, Chambon C, Communal Y, Chezal JM, Miot-Noirault E, Bouchon B, Degoul F.

Biochem Pharmacol. 2011 May 1;81(9):1116-23. doi: 10.1016/j.bcp.2011.02.014. Epub 2011 Mar 1.

PMID:
21371445
10.

Characterization of the Novel CMT Enzyme TEM-154.

Robin F, Delmas J, Machado E, Bouchon B, Peixe L, Bonnet R.

Antimicrob Agents Chemother. 2011 Mar;55(3):1262-5. doi: 10.1128/AAC.01359-10. Epub 2010 Dec 20.

11.

Characterization of the covalent binding of N-phenyl-N'-(2-chloroethyl)ureas to {beta}-tubulin: importance of Glu198 in microtubule stability.

Fortin S, Bouchon B, Chambon C, Lacroix J, Moreau E, Chezal JM, Degoul F, C-Gaudreault R.

J Pharmacol Exp Ther. 2011 Feb;336(2):460-7. doi: 10.1124/jpet.110.171082. Epub 2010 Oct 26.

PMID:
20978170
12.

B16 melanoma secretomes and in vitro invasiveness: syntenin as an invasion modulator.

Rondepierre F, Bouchon B, Bonnet M, Moins N, Chezal JM, D'Incan M, Degoul F.

Melanoma Res. 2010 Apr;20(2):77-84. doi: 10.1097/CMR.0b013e32833279f2.

PMID:
20016392
13.

Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination.

Rondepierre F, Bouchon B, Papon J, Bonnet-Duquennoy M, Kintossou R, Moins N, Maublant J, Madelmont JC, D'Incan M, Degoul F.

Biochim Biophys Acta. 2009 Jan;1794(1):61-9. doi: 10.1016/j.bbapap.2008.09.014. Epub 2008 Oct 8.

PMID:
18952200
14.

Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.

Desbois N, Gardette M, Papon J, Labarre P, Maisonial A, Auzeloux P, Lartigue C, Bouchon B, Debiton E, Blache Y, Chavignon O, Teulade JC, Maublant J, Madelmont JC, Moins N, Chezal JM.

Bioorg Med Chem. 2008 Aug 15;16(16):7671-90. doi: 10.1016/j.bmc.2008.07.015. Epub 2008 Jul 10.

PMID:
18656367
15.

Alkylation of prohibitin by cyclohexylphenyl-chloroethyl urea on an aspartyl residue is associated with cell cycle G(1) arrest in B16 cells.

Bouchon B, Papon J, Communal Y, Madelmont JC, Degoul F.

Br J Pharmacol. 2007 Oct;152(4):449-55. Epub 2007 Aug 20.

16.

N-(4-iodophenyl)-N'-(2-chloroethyl)urea as a microtubule disrupter: in vitro and in vivo profiling of antitumoral activity on CT-26 murine colon carcinoma cell line cultured and grafted to mice.

Borel M, Degoul F, Communal Y, Mounetou E, Bouchon B, C-Gaudreault R, Madelmont JC, Miot-Noirault E.

Br J Cancer. 2007 Jun 4;96(11):1684-91. Epub 2007 May 8.

17.

Production of a recombinant bacterial lipoprotein in higher plant chloroplasts.

Glenz K, Bouchon B, Stehle T, Wallich R, Simon MM, Warzecha H.

Nat Biotechnol. 2006 Jan;24(1):76-7. Epub 2005 Dec 4.

PMID:
16327810
18.

Preliminary studies of new proteasome inhibitors in the tumor targeting approach: synthesis and in vitro cytotoxicity.

Vivier M, Jarrousse AS, Bouchon B, Galmier MJ, Auzeloux P, Sauzieres J, Madelmont JC.

J Med Chem. 2005 Oct 20;48(21):6731-40.

PMID:
16220988
19.

Alkylation of beta-tubulin on Glu 198 by a microtubule disrupter.

Bouchon B, Chambon C, Mounetou E, Papon J, Miot-Noirault E, Gaudreault RC, Madelmont JC, Degoul F.

Mol Pharmacol. 2005 Nov;68(5):1415-22. Epub 2005 Aug 12.

PMID:
16099845
20.

Identification of degradation products of diclofenac by electrospray ion trap mass spectrometry.

Galmier MJ, Bouchon B, Madelmont JC, Mercier F, Pilotaz F, Lartigue C.

J Pharm Biomed Anal. 2005 Jul 15;38(4):790-6. Epub 2005 Mar 17.

PMID:
15967311
21.

Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.

Moreau MF, Papon J, Labarre P, Moins N, Borel M, Bayle M, Bouchon B, Madelmont JC.

Nucl Med Biol. 2005 May;32(4):377-84.

PMID:
15878507
22.
23.
24.

Factors associated with nurses' poor knowledge and practice of transfusion safety procedures in Aquitaine, France.

Saillour-Glénisson F, Tricaud S, Mathoulin-Pélissier S, Bouchon B, Galpérine I, Fialon P, Salmi LR.

Int J Qual Health Care. 2002 Feb;14(1):25-32.

PMID:
11871626
25.

Addition of acetaldehyde to the N-terminus of a recombinant Schistosoma mansoni glutathione S-transferase upon high-level expression in Saccharomyces cerevisiae.

Roecklin D, Klarskov K, Cavallini B, Sabatié J, Bouchon B, Loew D, Van Dorsselaer A, Bischoff R.

Eur J Biochem. 1997 May 1;245(3):589-99.

26.

Analysis of the lipidated recombinant outer surface protein A from Borrelia burgdorferi by mass spectrometry.

Bouchon B, Klein M, Bischoff R, Van Dorsselaer A, Roitsch C.

Anal Biochem. 1997 Mar 1;246(1):52-61.

PMID:
9056182
27.

Characterization of a schistosome T cell-stimulating antigen (Sm10) associated with protective immunity in humans.

Kohlstädt S, Couissinier-Paris P, Bourgois A, Bouchon B, Piper K, Kolbe H, Dessein AJ.

Mol Biochem Parasitol. 1997 Feb;84(2):155-65.

PMID:
9084036
28.
29.
30.

The Suppressor of fused gene encodes a novel PEST protein involved in Drosophila segment polarity establishment.

Pham A, Therond P, Alves G, Tournier FB, Busson D, Lamour-Isnard C, Bouchon BL, Préat T, Tricoire H.

Genetics. 1995 Jun;140(2):587-98.

31.

Analysis of the primary structure and post-translational modifications of the Schistosoma mansoni antigen Smp28 by electrospray mass spectrometry.

Bouchon B, Jaquinod M, Klarskov K, Trottein F, Klein M, Van Dorsselaer A, Bischoff R, Roitsch C.

J Chromatogr B Biomed Appl. 1994 Dec 9;662(2):279-90.

PMID:
7719482
32.

Recombinant cholera toxin B subunit in Escherichia coli: high-level secretion, purification, and characterization.

Slos P, Speck D, Accart N, Kolbe HV, Schubnel D, Bouchon B, Bischoff R, Kieny MP.

Protein Expr Purif. 1994 Oct;5(5):518-26.

PMID:
7827509
33.
34.

Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2.

Legrain M, Mazarin V, Irwin SW, Bouchon B, Quentin-Millet MJ, Jacobs E, Schryvers AB.

Gene. 1993 Aug 16;130(1):73-80.

PMID:
8344530
35.

Xenoxins, a family of peptides from dorsal gland secretion of Xenopus laevis related to snake venom cytotoxins and neurotoxins.

Kolbe HV, Huber A, Cordier P, Rasmussen UB, Bouchon B, Jaquinod M, Vlasak R, Délot EC, Kreil G.

J Biol Chem. 1993 Aug 5;268(22):16458-64.

36.

[The patient and his nutrition during bone marrow transplantation].

Bouchon B.

Soins. 1993 Aug-Sep;(575-576):54-62. French. No abstract available.

PMID:
8303429
37.

Characterization of multiple acylation sites on a recombinant protein by electrospray mass spectrometry.

Bouchon B, Van Dorsselaer A, Roitsch C.

Biol Mass Spectrom. 1993 Jun;22(6):358-60. No abstract available.

PMID:
8329466
38.

Production and characterization of a monoclonal antibody (BBH5) directed to ganglioside lactone.

Bouchon B, Levery SB, Clausen H, Hakomori S.

Glycoconj J. 1992 Feb;9(1):27-38.

PMID:
1392563
39.

Strategies for characterization of ganglioside inner esters. I--Fast atom bombardment mass spectrometry.

Levery SB, Salyan ME, Roberts CE, Bouchon B, Hakomori S.

Biomed Environ Mass Spectrom. 1990 May;19(5):303-10.

PMID:
2340365
40.

Evidence for several cell populations in human thyroid with distinct glycosphingolipid patterns.

Bouchon B, Portoukalian J, Madec AM, Orgiazzi J.

Biochim Biophys Acta. 1990 Jan 23;1051(1):1-5.

PMID:
2297535
41.

Selective expression of cholera toxin-receptor in rat medullary thymocytes.

Bouchon B, Iwamori M, Masago H, Nagai Y.

Cell Struct Funct. 1987 Aug;12(4):339-44.

42.

Selective enrichment of phytosphingosine in glycosphingolipids of isolated human thyrocytes as compared to the whole thyroid.

Bouchon B, Portoukalian J, Orgiazzi J, Bornet H.

Biochem Biophys Res Commun. 1987 Mar 30;143(3):827-31.

PMID:
3566758
43.

Hydrolysis of all gangliosides, including GM1 and GM2, on thin-layer plates by Vibrio cholerae neuraminidase.

Portoukalian J, Bouchon B.

J Chromatogr. 1986 Aug 2;380(2):386-92. No abstract available.

PMID:
3760066
44.

Alterations of the cerebroside fraction of human thyroid glycosphingolipids in Graves' disease.

Bouchon B, Portoukalian J, Bornet H.

Biochem Int. 1985 Sep;11(3):415-24.

PMID:
3840690
45.

Sex-specific difference of the galabiosylceramide level in the glycosphingolipids of human thyroid.

Bouchon B, Portoukalian J, Bornet H.

Biochim Biophys Acta. 1985 Aug 22;836(1):143-52.

PMID:
4027258
46.

Purification of the peracetylated glycosphingolipids of the gala series (galactosyl- and galabiosylceramides).

Bouchon B, Portoukalian J.

J Chromatogr. 1985 Aug 9;342(2):385-92. No abstract available.

PMID:
4055962
47.

Major gangliosides in normal and pathological human thyroids.

Bouchon B, Portoukalian J, Bornet H.

Biochem Int. 1985 Apr;10(4):531-8.

PMID:
3839677

Supplemental Content

Loading ...
Support Center